Comparing two treatments for narrowed neck arteries
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether adding a PCSK9 inhibitor to a statin is better than a statin alone for people with mild-to-moderate narrowing of the carotid artery (the main artery in the neck). It looks at how well these treatments slow plaque buildup and prevent strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have mild-to-moderate narrowing (plaque) in your carotid artery, confirmed by an imaging test like an ultrasound or CT scan.
- You have not had any symptoms (like a stroke or transient ischemic attack) from the narrowing.
- You do not plan to have surgery for the narrowing in the next 6 months.
- You are able to live independently (score of 2 or less on a scale of disability).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two tools—a balloon guide catheter and a filter—to make carotid artery stenting safer. It aims to prevent debris from reaching the brain during the procedure, which may reduce the risk of stroke.
This trial tests a special balloon (IVL) to treat hardened plaque in the neck arteries that supply blood to the brain. It is for people who need a stent but whose previous balloon treatment did not work well.
This trial tests a new type of stent placed through a small incision in the neck (not the groin) to treat a narrowed carotid artery, which can reduce the risk of stroke. You may be eligible if you have significant artery narrowing and are considered higher risk for traditional neck surgery.
This trial tests whether placing a stent in the narrowed carotid artery is a good option for people who are at high risk for the standard surgery (carotid endarterectomy). If you have significant blockages in your neck arteries and certain health or anatomical factors that make surgery riskier, this study may be for you.
This study tests a new class of cholesterol-lowering medicine (PCSK9 inhibitor) to see if it can make unstable plaques in the carotid artery more stable, reducing the risk of stroke. If you have carotid narrowing and high LDL despite statins, this might help prevent future problems.
This trial tests whether adding a PCSK9 inhibitor to standard statin therapy can help people with narrowing in brain arteries that hasn't caused symptoms yet. The goal is to see if this combination lowers plaque and prevents future strokes.
Hear when a new Carotid Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.